The UK government has announced that prescription charges for drugs in England will rise from L6.65 to L6.85 ($13.45) effective from April 1. The decision follows the Welsh Assembly's recent decision to scrap drug prescription charges for National Health Service patients on the same day (Marketletter February 26). About 87% of prescriptions are not charged, with exemptions for senior citizens, low-income families and other special cases, such as pregnant women and the unemployed.
Both contradictory pricing moves were announced by Labor party representatives: Brian Gibbons, Health Minister in Wales, and Lord Hunt, a junior Health Minister for England. In Wales, the decision to scrap the drug fee was supposedly taken "to ensure people are not put off getting medication they need because of cost," Mr Gibbons said.
However, the imminence of Welsh Assembly elections is likely to have played a role, given that in England, where no parliamentary elections are required before 2010, Lord Hunt focussed on the benefits of the increased charge for the delivery of NHS services. He said: "prescription charges are expected to raise some $425.0 million in 2007-2008. This is valuable income that can be ploughed back into the NHS."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze